fda statement bpc-157 Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Healing Ankle Injuries: PRP vs
Description
Anti-inflammatory signaling: TB-500 reduces inflammatory cytokine activity in the affected tissue environment
Chakravarty R, Goel S, Cai W
BPC-157: 0.5 mg daily, either as single dose or split 0.25 mg twice daily TB-500: 2-2.5 mg twice weekly (Monday/Thursday) totaling 4-5 mg per week Duration: 4-6 weeks loading phase, then 2-4 weeks maintenance Important: Use separate vials and syringes for each peptide
You follow post-treatment care instructions carefully
